Mucoepidermoid carcinoma (adenosquamous carcinoma) treated with Mohs micrographic surgery

Background  Mucoepidermoid carcinoma (MEC), sometimes referred to as adenosquamous carcinoma (ASC), is a common malignant tumor of the salivary glands that can also develop from the esophagus, lacrimal passages, lung, upper respiratory tract, pancreas, prostate and thyroid. Rarely, MEC will present...

Full description

Saved in:
Bibliographic Details
Published in:International journal of dermatology 2003-12, Vol.42 (12), p.957-959
Main Authors: Nouri, Keyvan, Trent, Jennifer T., Lowell, Brooke, Vaitla, Rama, Jimenez, Gloria P.
Format: Article
Language:English
Subjects:
Aged
Biological and medical sciences
Carcinoma, Adenosquamous - diagnosis
Carcinoma, Adenosquamous - pathology
Carcinoma, Adenosquamous - surgery
Dermatology
Diagnosis, Differential
Eyelids
Female
Humans
Medical sciences
Mohs Surgery
Skin Neoplasms - diagnosis
Skin Neoplasms - pathology
Skin Neoplasms - surgery
Skin plastic surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Tumors of the skin and soft tissue. Premalignant lesions
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background  Mucoepidermoid carcinoma (MEC), sometimes referred to as adenosquamous carcinoma (ASC), is a common malignant tumor of the salivary glands that can also develop from the esophagus, lacrimal passages, lung, upper respiratory tract, pancreas, prostate and thyroid. Rarely, MEC will present primarily in the skin. Case  We present a case of primary MEC of the lower eyelid treated successfully with Mohs micrographic surgery. Results  Mohs micrographic surgery was performed because of the highly aggressive and unpredictable nature of this tumor. The tumor was completely excised using Mohs with negative margins achieved in three stages. The patient has been disease free for 3 years since the surgery. Conclusion  We offer Mohs as an option for treating MEC.
ISSN:0011-9059
1365-4632
DOI:10.1111/j.1365-4632.2003.02076.x